Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Inventory: 2023

Historic Inventory for Seres Therapeutics (MCRB) over the last 1 years, with Dec 2023 value amounting to $29.6 million.

  • Seres Therapeutics' Inventory rose 892.45% to $53.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $53.0 million, marking a year-over-year increase of 892.45%. This contributed to the annual value of $29.6 million for FY2023, which is N/A change from last year.
  • Per Seres Therapeutics' latest filing, its Inventory stood at $29.6 million for FY2023.
  • Over the past 5 years, Seres Therapeutics' Inventory peaked at $29.6 million during FY2023, and registered a low of $29.6 million during FY2023.
  • Moreover, its 1-year median value for Inventory was $29.6 million (2023), whereas its average is $29.6 million.